missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Neisseria gonorrhoeae Polyclonal Antibody, Biotin

Description
The PA1-73145 antibody reacts with Neisseria gonorrhoeae. PA1-73145 has been successfully used in Immunohistochemical, ELISA, Immunofluorescence and Western blot applications. The PA1-73145 antibody was raised against whole N. gonorrhoeae; ATCC 31426.
Although pathogenic bacteria constitute only a small portion of bacterial species, infectious diseases caused by pathogenic bacteria affect millions of people worldwide. Diarrheal diseases, many of which are bacterial, are the second leading cause of death worldwide, claiming an estimated 5 million people annually. Furthermore, an estimated 3 million people die of tuberculosis annually, 500,000 people die of pertussis, and 25,000 die of typhoid. The ability of bacteria to utilize various food sources is a major factor behind their pervasiveness. Their vast numbers lead to rapid evolutionary changes resulting in emerging diseases as well as antibiotic-resistant strains of well known diseases. Examples of these are multi-drug resistant tuberculosis and methicillin-resistant Staphylococcus aureus. Research into the detection and treatment of these infectious disease agents will continue to expand in an effort to alleviate the effects of these diseases.
Specifications
Specifications
| Antigen | Neisseria gonorrhoeae |
| Applications | ELISA, Immunohistochemistry, Western Blot |
| Classification | Polyclonal |
| Concentration | 4-5 mg/mL |
| Conjugate | Biotin |
| Formulation | PBS with 0.1% sodium azide; pH 7.2 |
| Gene Alias | Gonococci; N. gonorrhoeae |
| Host Species | Rabbit |
| Immunogen | Whole N. gonorrhoeae; ATCC 31426. |
| Purification Method | IgG fraction |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?